Filtros de búsqueda

Lista de obras de Marco Lanza

Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain

artículo científico publicado en 2011

Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation.

artículo científico publicado en 2015

CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex.

artículo científico publicado en 1993

CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.

artículo científico publicado en 2012

CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons

scientific article published on 07 November 2019

Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex ⬇️

artículo científico publicado el 1 de agosto de 1997

Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons

artículo científico publicado en 2000

Cognition Enhancing Profile of CR 2249, a New NMDA-Glycine Site Modulator

Dendrimeric tetravalent ligands for the serotonin-gated ion channel

artículo científico publicado en 2014

Development of subnanomolar-affinity serotonin 5-HT receptor ligands based on quinoline structures

artículo científico publicado en 2018

Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis.

artículo científico publicado en 2017

Experimental pharmacology of glucosamine sulfate.

artículo científico

Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity

artículo científico publicado en 2013

Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.

artículo científico publicado en 2005

Improved efficacy, tolerance, safety and abuse liability profile of the combination CR4056-morphine over morphine alone in rodent models

scientific article published on 10 March 2020

Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats

artículo científico publicado en 2014

Multivalent ligands for the serotonin 5-HT receptor

artículo científico publicado en 2017

Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.

artículo científico publicado en 2018

Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds

artículo científico publicado en 2013

Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold

artículo científico publicado en 2014

Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis ⬇️

artículo científico publicado el 15 de agosto de 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda